Michael A. Augello

3.3k total citations
28 papers, 1.1k citations indexed

About

Michael A. Augello is a scholar working on Pulmonary and Respiratory Medicine, Molecular Biology and Oncology. According to data from OpenAlex, Michael A. Augello has authored 28 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Pulmonary and Respiratory Medicine, 13 papers in Molecular Biology and 9 papers in Oncology. Recurrent topics in Michael A. Augello's work include Prostate Cancer Treatment and Research (15 papers), Cancer-related Molecular Pathways (7 papers) and Ubiquitin and proteasome pathways (5 papers). Michael A. Augello is often cited by papers focused on Prostate Cancer Treatment and Research (15 papers), Cancer-related Molecular Pathways (7 papers) and Ubiquitin and proteasome pathways (5 papers). Michael A. Augello collaborates with scholars based in United States, Australia and Israel. Michael A. Augello's co-authors include Karen E. Knudsen, Theresa E. Hickey, Matthew J. Schiewer, Robert B. Den, Andrea Sboner, Christopher E. Barbieri, Clay E.S. Comstock, Deli Liu, Brian D. Robinson and Lesa D. Deonarine and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Clinical Investigation and Nature Communications.

In The Last Decade

Michael A. Augello

26 papers receiving 1.1k citations

Peers

Countries citing papers authored by Michael A. Augello

Since Specialization

Citations

This map shows the geographic impact of Michael A. Augello's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael A. Augello with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael A. Augello more than expected).

Fields of papers citing papers by Michael A. Augello

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael A. Augello. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael A. Augello. The network helps show where Michael A. Augello may publish in the future.

Co-authorship network of co-authors of Michael A. Augello

This figure shows the co-authorship network connecting the top 25 collaborators of Michael A. Augello. A scholar is included among the top collaborators of Michael A. Augello based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael A. Augello. Michael A. Augello is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Canonical androgen response element motifs are tumor suppressive regulatory elements in the prostate 2024 ·Nature Communications ·Xuanrong Chen, Michael A. Augello, Deli Liu, Kevin Lin, (unknown), Martin Sjöström, Francesca Khani, Lesa D. Deonarine, Yang Liu, (unknown), Jian Wu, (unknown), (unknown), Massimo Loda, Felix Y. Feng, Brian D. Robinson, Elai Davicioni, Andrea Sboner, Christopher E. Barbieri	6
2	A multidisciplinary approach to optimize primary prostate cancer biobanking 2022 ·Urologic Oncology Seminars and Original Investigations ·Peter Y. Cai, Muhammad Asad, Michael A. Augello, Laura Martin, Christopher Louie, Spyridon P. Basourakos, Christopher Gaffney, Jonathan E. Shoag, Jiangling Tu, Francesca Khani, Juan Miguel Mosquera, Massimo Loda, Douglas S. Scherr, Christopher E. Barbieri, Brian D. Robinson	1
3	Tumor subtype defines distinct pathways of molecular and clinical progression in primary prostate cancer 2021 ·Journal of Clinical Investigation ·Deli Liu, Michael A. Augello, Ivana Grbeša, Davide Prandi, Yang Liu, Jonathan E. Shoag, R. Jeffrey Karnes, Bruce J. Trock, Eric A. Klein, Robert B. Den, Francesca Demichelis, Elai Davicioni, Andrea Sboner, Christopher E. Barbieri	27
4	Reshaping of the androgen-driven chromatin landscape in normal prostate cells by early cancer drivers and effect on therapeutic sensitivity 2021 ·Cell Reports ·Ivana Grbeša, Michael A. Augello, Deli Liu, Dylan McNally, Christopher Gaffney, Dennis Huang, Kevin Lin, (unknown), Ramy Goueli, Brian D. Robinson, Francesca Khani, Lesa D. Deonarine, Mirjam Blattner, Olivier Elemento, Elai Davicioni, Andrea Sboner, Christopher E. Barbieri	23
5	N-Myc–mediated epigenetic reprogramming drives lineage plasticity in advanced prostate cancer 2019 ·Journal of Clinical Investigation ·Adeline Berger, Nicholas J. Brady, Rohan Bareja, Brian Robinson, Vincenza Conteduca, Michael A. Augello, Loredana Puca, Adnan Ahmed, Étienne Dardenne, Xiaodong Lü, Inah Hwang, (unknown), Andrea Sboner, Olivier Elemento, Jihye Paik, Jindan Yu, Christopher E. Barbieri, Noah Dephoure, Himisha Beltran, David S. Rickman	116
6	MAPK Reliance via Acquired CDK4/6 Inhibitor Resistance in Cancer 2018 ·Clinical Cancer Research ·Renée de Leeuw, Christopher McNair, Matthew J. Schiewer, Neermala Poudel Neupane, Lucas J. Brand, Michael A. Augello, Zhen Li, Larry C. Cheng, Akihiro Yoshida, Sean M. Courtney, E. Starr Hazard, Gary Hardiman, Maha Hussain, J. Alan Diehl, Justin M. Drake, Wm. Kevin Kelly, Karen E. Knudsen	77
7	SPOP Mutation Drives Prostate Tumorigenesis In Vivo through Coordinate Regulation of PI3K/mTOR and AR Signaling 2017 ·Cancer Cell ·Mirjam Blattner, Deli Liu, Brian D. Robinson, Dennis Huang, Anton Poliakov, Dong Gao, Srilakshmi Nataraj, Lesa D. Deonarine, Michael A. Augello, Verena Sailer, Lalit Ponnala, Michael Ittmann, Arul M. Chinnaiyan, Andrea Sboner, Yu Chen, Mark A. Rubin, Christopher E. Barbieri	140
8	Consequence of the tumor‐associated conversion to cyclin D1b 2015 ·EMBO Molecular Medicine ·Michael A. Augello, Lisa D. Berman-Booty, Richard W. Carr, Akihiro Yoshida, Jeffry L. Dean, Matthew J. Schiewer, Felix Y. Feng, Scott A. Tomlins, Erhe Gao, Walter J. Koch, Jeffrey Benovic, J. Alan Diehl, Karen E. Knudsen	15
9	Aberrant BAF57 Signaling Facilitates Prometastatic Phenotypes 2013 ·Clinical Cancer Research ·(unknown), Clay E.S. Comstock, Adam Ertel, Kwang Won Jeong, Michael R. Stallcup, Sankar Addya, Peter A. McCue, (unknown), Michael A. Augello, Karen E. Knudsen	31
10	Targeting cell cycle and hormone receptor pathways in cancer 2013 ·Oncogene ·Clay E.S. Comstock, Michael A. Augello, Jonathan F. Goodwin, Renée de Leeuw, Matthew J. Schiewer, (unknown), Richard A. Burkhart, A. Kathleen McClendon, Peter A. McCue, Edouard J. Trabulsi, Costas D. Lallas, Leonard G. Gomella, Margaret M. Centenera, Jonathan R. Brody, Lisa M. Butler, Wayne D. Tilley, Karen E. Knudsen	81
11	Convergence of oncogenic and hormone receptor pathways promotes metastatic phenotypes 2012 ·Journal of Clinical Investigation ·Michael A. Augello, Craig J. Burd, Ruth Birbe, Christopher McNair, Adam Ertel, Michael S. Magee, Daniel E. Frigo, Kari Wilder-Romans, Mark Shilkrut, Sumin Han, Danielle L. Jernigan, Jeffry L. Dean, Alessandro Fatatis, Donald P. McDonnell, Tapio Visakorpi, Felix Y. Feng, Karen E. Knudsen	35
12	mTOR is a selective effector of the radiation therapy response in androgen receptor-positive prostate cancer 2011 ·Endocrine Related Cancer ·Matthew J. Schiewer, Robert B. Den, David T. Hoang, Michael A. Augello, Yaacov Richard Lawrence, Adam P. Dicker, Karen E. Knudsen	34
13	Cyclin D1 Is a Selective Modifier of Androgen-dependent Signaling and Androgen Receptor Function 2011 ·Journal of Biological Chemistry ·Clay E.S. Comstock, Michael A. Augello, Matthew J. Schiewer, Jason Karch, Craig J. Burd, Adam Ertel, Erik S. Knudsen, Walter J. Jessen, Bruce J. Aronow, Karen E. Knudsen	30
14	Risk factors for sedation‐related events during procedural sedation in the emergency department 2011 ·Emergency Medicine Australasia ·David McD Taylor, Anthony Bell, Anna Holdgate, Catherine E MacBean, Truc T. Huynh, Ogilvie Thom, Michael A. Augello, (unknown), (unknown), Aled Williams, Peter Ritchie, (unknown)	36
15	FOXA1: master of steroid receptor function in cancer 2011 ·The EMBO Journal ·Michael A. Augello, Theresa E. Hickey, Karen E. Knudsen	144
16	The AR dependent cell cycle: Mechanisms and cancer relevance 2011 ·Molecular and Cellular Endocrinology ·Matthew J. Schiewer, Michael A. Augello, Karen E. Knudsen	47
17	Factors associated with failure to successfully complete a procedure during emergency department sedation 2011 ·Emergency Medicine Australasia ·Anna Holdgate, David McD Taylor, Anthony Bell, Catherine E MacBean, Truc T. Huynh, Ogilvie Thom, Michael A. Augello, (unknown), (unknown), Aled Williams, Peter Ritchie, (unknown)	10
18	Procedural sedation practices in Australian Emergency Departments 2011 ·Emergency Medicine Australasia ·Anthony Bell, David McD Taylor, Anna Holdgate, Catherine E MacBean, Truc T. Huynh, Ogilvie Thom, Michael A. Augello, (unknown), (unknown), Aled Williams, Peter Ritchie, (unknown)	16
19	Identification of ASF/SF2 as a Critical, Allele-Specific Effector of the Cyclin D1b Oncogene 2010 ·Cancer Research ·(unknown), Clay E.S. Comstock, Matthew J. Schiewer, Michael A. Augello, Terry Hyslop, Claudio Sette, Jinsong Zhang, Linda M. Parysek, Karen E. Knudsen	57
20	Delayed versus immediate urethral catheterization following instillation of local anaesthetic gel in men: A randomized, controlled clinical trial 2008 ·Emergency Medicine Australasia ·(unknown), David McD Taylor, (unknown), Michael A. Augello	5

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact